What is BBOT's dilution risk score?

BBOT has a latest available DilutionScore record of 56/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for BBOT, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for BBOT?

DilutionWatch tracks 25 SEC filing types for BBOT including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect BBOT shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For BBOT, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for BBOT tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for BBOT. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

BBOT Dilution Risk Score: 56/100 (HIGH)

Score Breakdown

📋 Offering Ability

60

💰 Cash Runway

25

📊 Float Risk

45

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 0%

No significant dilution signals detected for BBOT.

🔔 Track BBOT — Get forecast alerts →

Market Data

Market Cap$718.56M

Shares Outstanding80.17M

Float35.75M

Cash$225.71M

Debt$2.64M

Short InterestN/A

Institutional Holdings

QoQ: ↓ 3.0% shares (2026Q1 vs prior)

67 institutional holders · 58.23M shares

#1 Cormorant Asset Management, LP 17.88M shares

#2 DEERFIELD MANAGEMENT COMPANY, L.P. 4.89M shares

#3 Omega Fund Management, LLC 3.29M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.83M

Days to Cover20.8

% of Float16.3%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31

3 FORM3 2026-04-30

424B3 ATM 2026-04-29

424B3 ATM 2026-04-23

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual BBOT Dilution Snapshot

BridgeBio Oncology Therapeutics, Inc. (BBOT) has a DilutionScore of 56/100, rated High dilution risk. Score date: August 28, 2026.

Recent SEC activity tracked for BBOT: 3 on 2026-04-30; 3 on 2026-04-30; 424B3 on 2026-04-29.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.